Market Cap 10.37B
Revenue (ttm) 0.00
Net Income (ttm) -380.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,492,500
Avg Vol 2,377,716
Day's Range N/A - N/A
Shares Out 87.25M
Stochastic %K 31%
Beta 0.87
Analysts Strong Sell
Price Target $162.75

Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Industry: Biotechnology
Sector: Healthcare
Phone: 33 1 53 83 09 63
Address:
7-11 Boulevard Haussmann, Paris, France
StrongUptrends
StrongUptrends Jul. 30 at 10:15 PM
$ABVX $BCRX bio holds
0 · Reply
DipinDipout
DipinDipout Jul. 30 at 10:08 AM
$ABVX blocked and reported, SLS KIDS
0 · Reply
Jesse1011
Jesse1011 Jul. 30 at 7:00 AM
$ABVX $SLS yeppp
0 · Reply
Fairvalue10
Fairvalue10 Jul. 30 at 5:12 AM
$ABVX @55X_ROI_Q1_2026 Now I’m telling you nicely: stop busting our balls and post on the right board with your 50 shares…
1 · Reply
Fairvalue10
Fairvalue10 Jul. 30 at 5:04 AM
$ABVX Sharing this purely as a public service, since you clearly weren’t going to find it on your own: there is an SLS board. Shocking, I know. So do us all a favour and drop it.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 30 at 5:02 AM
$SLS $ABVX was bumping around $5 and change ahead of it P3 - it had doubled to $10 the day the P3 was announced - there was a T1 Level Trading Halt and a +600% GAP Up at the Open to $60 per Share and it Kept Climbing to a high of $148. From $5 to $148 - this is the Accretive Value of Phase 3 Registrational results like those that are Now Imminent at SLS... 5 Years in the making - Now IMMINENT. Just Be Holding.
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 30 at 12:31 AM
$SLS $ABVX was bumping around $5 and change ahead of it P3 - it had doubled to $10 the day the P3 was announced - there was a T1 Level Trading Halt and a +600% GAP Up at the Open to $60 per Share and it Kept Climbing to a high of $148. From $5 to $148 - this is the Accretive Value of Phase 3 Registrational results like those that are Now Imminent at SLS... 5 Years in the making - Now IMMINENT.
1 · Reply
itsphd
itsphd Jul. 29 at 8:39 PM
$ABVX Bought some at 119.62 after hours.
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 29 at 7:25 PM
$ABVX it’s cooked
1 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 29 at 5:55 PM
$ABVX way too easy for the MMs with this pathetic volume
1 · Reply
Latest News on ABVX
ABIVAX Société Anonyme Slides: Corporate presentation

Jul 10, 2026, 2:00 AM EDT - 20 days ago

ABIVAX Société Anonyme Slides: Corporate presentation


Abivax Announces Closing of $920 Million Public Offering

Jul 6, 2026, 4:05 PM EDT - 24 days ago

Abivax Announces Closing of $920 Million Public Offering

ABVX


ABIVAX Société Anonyme Transcript: Study result

Jun 29, 2026, 4:30 PM EDT - 4 weeks ago

ABIVAX Société Anonyme Transcript: Study result


ABIVAX Société Anonyme Press release: Study result

Jun 29, 2026, 4:30 PM EDT - 4 weeks ago

ABIVAX Société Anonyme Press release: Study result


ABIVAX Société Anonyme Slides: Study result

Jun 29, 2026, 4:30 PM EDT - 4 weeks ago

ABIVAX Société Anonyme Slides: Study result


ABIVAX Société Anonyme Transcript: Study result

Jun 1, 2026, 4:30 PM EDT - 2 months ago

ABIVAX Société Anonyme Transcript: Study result


ABIVAX Société Anonyme Press release: Study result

Jun 1, 2026, 4:30 PM EDT - 2 months ago

ABIVAX Société Anonyme Press release: Study result


ABIVAX Société Anonyme Slides: Study result

Jun 1, 2026, 4:30 PM EDT - 2 months ago

ABIVAX Société Anonyme Slides: Study result


ABIVAX Société Anonyme Earnings release: Q1 2026

May 22, 2026, 11:40 AM EDT - 2 months ago

ABIVAX Société Anonyme Earnings release: Q1 2026


ABIVAX Société Anonyme Earnings release: Q1 2026

May 22, 2026, 11:40 AM EDT - 2 months ago

ABIVAX Société Anonyme Earnings release: Q1 2026


ABIVAX Société Anonyme Annual report: Q4 2025

Mar 23, 2026, 12:45 PM EDT - 4 months ago

ABIVAX Société Anonyme Annual report: Q4 2025


ABIVAX Société Anonyme Earnings release: Q4 2025

Mar 23, 2026, 12:45 PM EDT - 4 months ago

ABIVAX Société Anonyme Earnings release: Q4 2025


Abivax CEO dismisses 'noise' around rumored Eli Lilly bid

Jan 20, 2026, 6:01 AM EST - 6 months ago

Abivax CEO dismisses 'noise' around rumored Eli Lilly bid

ABVX LLY


Abivax stock rockets 30% on Eli Lilly takeover speculation

Jan 12, 2026, 9:32 AM EST - 7 months ago

Abivax stock rockets 30% on Eli Lilly takeover speculation

ABVX LLY


Abivax shares soar 23% as media report reignites M&A chatter

Jan 12, 2026, 4:38 AM EST - 7 months ago

Abivax shares soar 23% as media report reignites M&A chatter

ABVX LLY


Abivax Provides 2026 Corporate Outlook

Jan 7, 2026, 4:05 PM EST - 7 months ago

Abivax Provides 2026 Corporate Outlook

ABVX


Abivax to be Added to Nasdaq Biotechnology Index

Dec 18, 2025, 4:05 PM EST - 8 months ago

Abivax to be Added to Nasdaq Biotechnology Index

ABVX


ABIVAX Société Anonyme Earnings release: Q3 2025

Dec 15, 2025, 11:45 AM EST - 8 months ago

ABIVAX Société Anonyme Earnings release: Q3 2025


French biotech Abivax's shares climb on Eli Lilly bid rumors

Dec 10, 2025, 5:52 AM EST - 8 months ago

French biotech Abivax's shares climb on Eli Lilly bid rumors

ABVX LLY


ABIVAX Société Anonyme Press release: FY 2025

Oct 6, 2025, 9:00 AM EDT - 10 months ago

ABIVAX Société Anonyme Press release: FY 2025


ABIVAX Société Anonyme Slides: FY 2025

Oct 6, 2025, 9:00 AM EDT - 10 months ago

ABIVAX Société Anonyme Slides: FY 2025


Abivax Presents First Half 2025 Financial Results

Sep 8, 2025, 4:00 PM EDT - 11 months ago

Abivax Presents First Half 2025 Financial Results

ABVX


ABIVAX Société Anonyme Quarterly report: Q2 2025

Sep 8, 2025, 11:45 AM EDT - 11 months ago

ABIVAX Société Anonyme Quarterly report: Q2 2025


ABIVAX Société Anonyme Earnings release: Q2 2025

Sep 8, 2025, 11:45 AM EDT - 11 months ago

ABIVAX Société Anonyme Earnings release: Q2 2025


How Hedge Funds Won Big on an Obscure Drugmaker

Aug 30, 2025, 5:30 AM EDT - 11 months ago

How Hedge Funds Won Big on an Obscure Drugmaker

ABVX


Abivax Announces Closing of $747.5 Million Public Offering

Jul 28, 2025, 4:15 PM EDT - 1 year ago

Abivax Announces Closing of $747.5 Million Public Offering

ABVX


Abivax Announces Launch of Public Offering

Jul 23, 2025, 4:15 PM EDT - 1 year ago

Abivax Announces Launch of Public Offering

ABVX


StrongUptrends
StrongUptrends Jul. 30 at 10:15 PM
$ABVX $BCRX bio holds
0 · Reply
DipinDipout
DipinDipout Jul. 30 at 10:08 AM
$ABVX blocked and reported, SLS KIDS
0 · Reply
Jesse1011
Jesse1011 Jul. 30 at 7:00 AM
$ABVX $SLS yeppp
0 · Reply
Fairvalue10
Fairvalue10 Jul. 30 at 5:12 AM
$ABVX @55X_ROI_Q1_2026 Now I’m telling you nicely: stop busting our balls and post on the right board with your 50 shares…
1 · Reply
Fairvalue10
Fairvalue10 Jul. 30 at 5:04 AM
$ABVX Sharing this purely as a public service, since you clearly weren’t going to find it on your own: there is an SLS board. Shocking, I know. So do us all a favour and drop it.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 30 at 5:02 AM
$SLS $ABVX was bumping around $5 and change ahead of it P3 - it had doubled to $10 the day the P3 was announced - there was a T1 Level Trading Halt and a +600% GAP Up at the Open to $60 per Share and it Kept Climbing to a high of $148. From $5 to $148 - this is the Accretive Value of Phase 3 Registrational results like those that are Now Imminent at SLS... 5 Years in the making - Now IMMINENT. Just Be Holding.
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 30 at 12:31 AM
$SLS $ABVX was bumping around $5 and change ahead of it P3 - it had doubled to $10 the day the P3 was announced - there was a T1 Level Trading Halt and a +600% GAP Up at the Open to $60 per Share and it Kept Climbing to a high of $148. From $5 to $148 - this is the Accretive Value of Phase 3 Registrational results like those that are Now Imminent at SLS... 5 Years in the making - Now IMMINENT.
1 · Reply
itsphd
itsphd Jul. 29 at 8:39 PM
$ABVX Bought some at 119.62 after hours.
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 29 at 7:25 PM
$ABVX it’s cooked
1 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 29 at 5:55 PM
$ABVX way too easy for the MMs with this pathetic volume
1 · Reply
Machiaveltrade
Machiaveltrade Jul. 29 at 4:55 PM
$ABVX happy shopping day 😁
0 · Reply
Pihedgy
Pihedgy Jul. 29 at 2:02 PM
$ABVX absolutely ass price action. It’ll get worse too.
1 · Reply
ScanStock
ScanStock Jul. 28 at 10:05 PM
Big bulls calling you APUS right now for a run! Looks like they might be right, Loads of bulls moving to APUS now! The next low float stock to squeeze north Look APUS starting to run with fresh news < $ECOX.X $GOAI $ABVX $BCRX now
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 28 at 8:44 PM
$SLS The Instant the Registrational Results are Announced -- GPS Phase 3 MOS of 34-36 Months for CR2/3 vs ~ 8 for Control --- - the market will Instantly Price in $20+B in additional Value - Gps is worth $50B to Big Pharma - and it is Happening - ANY DAY NOW - the FUTURE is Inevitable, and Shares are on Sale for a Huge Discount. The Top Line are All That Matters - GPS Pristine Safety, Manufacture already FDA Approved --- there is no PDUFA intrigue. Same Thing that happened at $ABVX when they released their P3 Top Line will be Happening Here -- Eerily Similar ABVX was bumping around $5 and Change, and had climbed to $10 the Day the P3 was Announced -- T1 Trading Halt Followed by a GAP UP +600% +600% in An Instant to $60 Per Share and it Kept Climbing to a High of $148 Just Be Holding.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 28 at 6:21 PM
$SLS --- The Instant the Registrational Results are Announced -- GPS Phase 3 MOS of 34-36 Months for CR2/3 vs ~ 8 for Control --- - the entire market will Instantly Price in $20+B in additional Market Value - Gps is worth $50B to Big Pharma - and it is Happening - ANY DAY NOW - the FUTURE is Inevitable, and Shares are on Sale for a Huge Discount. The Top Line are All That Matters - GPS Pristine Safety, Manufacture already FDA Approved --- there is no PDUFA intrigue. Same Thing that happened at $ABVX when they released their P3 Top Line will be Happening Here -- Eerily Similar ABVX was bumping around $5 and Change, and had climbed to $10 the Day the P3 was Announced -- T1 Trading Halt Followed by a GAP UP +600% +600% in An Instant to $60 Per Share and it Kept Climbing to a High of $148 Just Be Holding.
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 28 at 5:53 PM
$CAPR don’t waste your money here, come to a real bio $ABVX
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 28 at 4:12 PM
$SLS -- GPS MOS of 34-36 Months for CR2/3 vs ~ 8 for Control --- - the entire market will Instantly Price in $20+B in additional Market Value The Top Line are All That Matters - GPS Pristine Safety, Manufacture already FDA Approved --- there is no PDUFA intrigue. Same Thing that happened at $ABVX when they released their P3 Top Line will be Happening Here -- Eerily Similar ABVX was bumping around $5 and Change, and had climbed to $10 the Day the P3 was Announced -- T1 Trading Halt Followed by a GAP UP +600% +600% in An Instant to $60 Per Share and it Kept Climbing to a High of $148 Just Be Holding. --- The Instant the Registrational Results are Announced - Gps is worth $50B to Big Pharma - and it is Happening - ANY DAY NOW - the FUTURE is Inevitable, and Shares are on Sale for a Huge Discount. just sayin.
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 28 at 2:19 PM
1 · Reply
BioRich
BioRich Jul. 28 at 1:19 PM
$ALT Congrats on the AUD data. Today's news moves $ALT to my #2 holding behind $GUTS. Top 5 rounded out by $MIST, $KYTX and $ABVX
1 · Reply
TechnoFunctional
TechnoFunctional Jul. 28 at 3:03 AM
$ABVX FDA preliminary response will be available to the management anythime in the next 24 hrs. If it is squeaky clean it will put an official stamp of 'derisked' on it. Retail investors have been baffled at $ABVX underperformance post Ph-3 readout, IMO it is because intitutional investors (other than who participated in the raise) are waiting for the FDA response. Experts on X and here can shout all they want about Obe being already de-risked, it is not till FDA preliminary response is clean. I believe that if it is clean, $ABVX will re-rate.
2 · Reply